Paper36937280
Synergistic antibacterial effects of ultrasound combined nanoparticles encapsulated with cellulase and levofloxacin on Bacillus Calmette-Guérin biofilms.
Zhang Z and 6 others. Front Microbiol, 2023. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Synergistic antibacterial effects of ultrasound combined nanoparticles encapsulated with cellulase and levofloxacin on Bacillus Calmette-Guérin biofilms. Papers, record 36937280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36937280
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergistic antibacterial effects of ultrasound combined nanoparticles encapsulated with cellulase and levofloxacin on Bacillus Calmette-Guérin biofilms.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32979656 | Precise magnetic resonance imaging-guided sonodynamic therapy for drug-resistant bacterial deep infection. | Biomaterials | 2021 | https://conductscience.org/library/papers/32979656 | PubMed |
| 2 | 3958392 | Occupational asthma caused by cellulase. | J Allergy Clin Immunol | 1986 | https://conductscience.org/library/papers/3958392 | PubMed |
| 3 | 29280609 | New Perspectives in Biofilm Eradication. | ACS Infect Dis | 2018 | https://conductscience.org/library/papers/29280609 | PubMed |
| 4 | 27000525 | Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: A combinatorial study with azithromycin and gentamicin. | Sci Rep | 2016 | https://conductscience.org/library/papers/27000525 | PubMed |
| 5 | 34193133 | Challenges in delivery of tuberculosis Services in Ethiopian Pastoralist Settings: clues for reforming service models and organizational structures. | BMC Health Serv Res | 2021 | https://conductscience.org/library/papers/34193133 | PubMed |
| 6 | 33707445 | Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis. | Nat Commun | 2021 | https://conductscience.org/library/papers/33707445 | PubMed |
| 7 | 19465435 | Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. | J Antimicrob Chemother | 2009 | https://conductscience.org/library/papers/19465435 | PubMed |
| 8 | 28760936 | Caspase-11 Plays a Protective Role in Pulmonary Acinetobacter baumannii Infection. | Infect Immun | 2017 | https://conductscience.org/library/papers/28760936 | PubMed |
| 9 | 28168306 | Characterization of a mycobacterial cellulase and its impact on biofilm- and drug-induced cellulose production. | Glycobiology | 2017 | https://conductscience.org/library/papers/28168306 | PubMed |
| 10 | 31278356 | Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells. | Sci Rep | 2019 | https://conductscience.org/library/papers/31278356 | PubMed |
| 11 | 34235666 | Whole-Genome Sequencing of Mycobacterium tuberculosis Directly from Sputum Samples. | Methods Mol Biol | 2021 | https://conductscience.org/library/papers/34235666 | PubMed |
| 12 | 26456916 | PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. | Adv Drug Deliv Rev | 2016 | https://conductscience.org/library/papers/26456916 | PubMed |
| 13 | 24408988 | Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae. | J Antimicrob Chemother | 2014 | https://conductscience.org/library/papers/24408988 | PubMed |
| 14 | 34669372 | Photoactivatable Nitric Oxide-Releasing Gold Nanocages for Enhanced Hyperthermia Treatment of Biofilm-Associated Infections. | ACS Appl Mater Interfaces | 2021 | https://conductscience.org/library/papers/34669372 | PubMed |
| 15 | 32942991 | A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette-Guérin (BCG) against Mycobacterium tuberculosis. | BMC Infect Dis | 2020 | https://conductscience.org/library/papers/32942991 | PubMed |
| 16 | 33273606 | Epithelial processed Mycobacterium avium subsp. paratuberculosis induced prolonged Th17 response and suppression of phagocytic maturation in bovine peripheral blood mononuclear cells. | Sci Rep | 2020 | https://conductscience.org/library/papers/33273606 | PubMed |
| 17 | 11502517 | Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11502517 | PubMed |
| 18 | 20000921 | Passive cavitation imaging with ultrasound arrays. | J Acoust Soc Am | 2009 | https://conductscience.org/library/papers/20000921 | PubMed |
| 19 | 33868212 | A Novel Small Molecule, LCG-N25, Inhibits Oral Streptococcal Biofilm. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33868212 | PubMed |
| 20 | 30715289 | Effects of low-intensity and low-frequency ultrasound combined with tobramycin on biofilms of extended-spectrum beta-lactamases (ESBLs) Escherichia coli. | FEMS Microbiol Lett | 2019 | https://conductscience.org/library/papers/30715289 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42010113 | Low-frequency ultrasound-assisted application of Ag/Cu nanocomposites as a promising strategy for the treatment of purulent wounds. | Discov Nano | 2026 | https://conductscience.org/library/papers/42010113 | PubMed |
| 40980328 | Progress of anti-tuberculosis drug targets and novel therapeutic strategies. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40980328 | PubMed |
| 40583903 | In vitro evaluation of antimicrobial, antitumor, and anti-SARS-cov-2 properties of cellulase enzyme produced by Aspergillus niger. | Biochem Biophys Rep | 2025 | https://conductscience.org/library/papers/40583903 | PubMed |
| 39961217 | Ultrasound-mediated nanomaterials for the treatment of inflammatory diseases. | Ultrason Sonochem | 2025 | https://conductscience.org/library/papers/39961217 | PubMed |
| 39502292 | Mycobacteria develop biofilms on airway epithelial cells and promote mucosal barrier disruption. | iScience | 2024 | https://conductscience.org/library/papers/39502292 | PubMed |
| 39385196 | US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39385196 | PubMed |
| 39343957 | Thermothelomyces thermophilus exo- and endo-glucanases as tools for pathogenic E. coli biofilm degradation. | Sci Rep | 2024 | https://conductscience.org/library/papers/39343957 | PubMed |
| 39063012 | Mycobacterial Biofilm: Mechanisms, Clinical Problems, and Treatments. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39063012 | PubMed |
| 38783925 | Breaking barriers: The potential of nanosystems in antituberculosis therapy. | Bioact Mater | 2024 | https://conductscience.org/library/papers/38783925 | PubMed |
| 37936950 | An Oxygen Supply Strategy for Sonodynamic Therapy in Tuberculous Granuloma Lesions Using a Catalase-Loaded Nanoplatform. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/37936950 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36937280
GET https://conductscience.org/api/papers/v1/36937280/references?page=2